These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 12869883

  • 1. Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine.
    Paré P, Armstrong D, Pericak D, Pyzyk M.
    J Clin Gastroenterol; 2003 Aug; 37(2):132-8. PubMed ID: 12869883
    [Abstract] [Full Text] [Related]

  • 2. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care.
    Talley NJ, Moore MG, Sprogis A, Katelaris P.
    Med J Aust; 2002 Oct 21; 177(8):423-7. PubMed ID: 12381251
    [Abstract] [Full Text] [Related]

  • 8. Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial.
    Madan K, Ahuja V, Kashyap PC, Sharma MP.
    Dis Esophagus; 2004 Oct 21; 17(4):274-8. PubMed ID: 15569362
    [Abstract] [Full Text] [Related]

  • 9. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.
    Paré P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R.
    Can J Gastroenterol; 2003 May 21; 17(5):307-12. PubMed ID: 12772004
    [Abstract] [Full Text] [Related]

  • 10. Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease.
    Tolia V, Bishop PR, Tsou VM, Gremse D, Soffer EF, Comer GM, Members of the 322 Study Group.
    J Pediatr Gastroenterol Nutr; 2006 Apr 21; 42(4):384-91. PubMed ID: 16641576
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T, Schütze K, van Leendert RJ, Fumagalli I, Costa Neves B, Bohuschke M, Gatz G.
    Digestion; 2003 Apr 21; 67(1-2):6-13. PubMed ID: 12743434
    [Abstract] [Full Text] [Related]

  • 17. 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.
    Gillessen A, Beil W, Modlin IM, Gatz G, Hole U.
    J Clin Gastroenterol; 2004 Apr 21; 38(4):332-40. PubMed ID: 15087692
    [Abstract] [Full Text] [Related]

  • 18. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL, Houcke P, Samoyeau R, French Collaborative Pantaprazole Study Group.
    Gastroenterol Clin Biol; 2001 Mar 21; 25(3):245-50. PubMed ID: 11395670
    [Abstract] [Full Text] [Related]

  • 19. Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.
    Calleja JL, Suarez M, De Tejada AH, Navarro A, Pantogerd Group.
    Dig Dis Sci; 2005 Mar 21; 50(3):432-9. PubMed ID: 15810621
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.